文献速递创伤与烧伤重症综合管理与镇静镇痛

新型凝血酶生成平台对创伤后静脉血栓栓塞早期预测的评估:一项前瞻性队列研究

Assessment of Novel Platform of Thrombin Generation to Predict Venous Thromboembolism Early After Traumatic Injury: A Prospective Cohort Study.
PubMed 文献 · Shock · 2026-03-20
一句话结论创伤后12小时内采用ST Genesia检测凝血酶生成谱,可区分后续发生症状性静脉血栓栓塞的高风险患者。

本研究为前瞻性队列研究,纳入一级创伤中心254例创伤患者,伤后12小时内采血,用ST Genesia高通量凝血酶生成检测平台分析凝血酶生成谱,随访至90天。64例(25.2%)发生症状性静脉血栓栓塞,中位发生时间8天。发生静脉血栓栓塞的患者凝血酶生成加速,峰值高度(P=0.001)、达峰时间(P=0.021)、内源性凝血酶潜能(P<0.001)和速度指数(P=0.001)与未发生者差异有统计学意义。作者认为该平台可区分创伤后静脉血栓栓塞高风险患者,适合需要高通量批量检测的临床实验室。

要点

  • 254例创伤患者伤后12小时内采血,64例(25.2%)随访90天内发生症状性静脉血栓栓塞,中位时间8天。
  • 发生静脉血栓栓塞者凝血酶生成加速:峰值高度P=0.001、达峰时间P=0.021、内源性凝血酶潜能P<0.001、速度指数P=0.001。
  • 静脉血栓栓塞患者中29例深静脉血栓、24例肺栓塞、11例深静脉血栓合并肺栓塞。
  • 发生静脉血栓栓塞者24小时内接受手术和输血的比例显著更多,年龄、性别、体重指数无显著差异。
  • 作者认为ST Genesia凝血酶生成谱可区分创伤后静脉血栓栓塞高风险患者,适合需要高通量批量检测的临床实验室。

适用人群与场景

  • 就诊于一级创伤中心的创伤患者,伤后12小时内采集血样,前瞻性随访至90天。

研究设计与关键结果

  • 前瞻性队列研究,254例创伤患者[48.5岁(31.0,62.0),72.0%男性],其中静脉血栓栓塞64例(25.2%)、非静脉血栓栓塞190例。
  • 静脉血栓栓塞患者中位发生时间8天,29例深静脉血栓、24例肺栓塞、11例深静脉血栓合并肺栓塞。
  • 年龄、性别、体重指数在两组间无显著差异;静脉血栓栓塞患者24小时内接受手术和输血者显著更多。
  • 发生静脉血栓栓塞者凝血酶生成加速,峰值高度P=0.001、达峰时间P=0.021、内源性凝血酶潜能P<0.001、速度指数P=0.001。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究;证据等级:II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,使用ST Genesia的凝血酶生成谱可区分创伤后静脉血栓栓塞高风险患者。
  • 作者认为,该平台通过批量检测能力适合需要高通量的临床实验室。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Calibrated automated thrombogram assay parameters have been shown to assess hypercoagulation state and, therefore, may independently predict posttrauma, symptomatic venous thromboembolism (VTE). Yet, calibrated automated thrombogram lacks high throughput and standardization, limiting diagnostic potential. This study analyzed thrombin generation (TG) profiles in trauma patients using a high-throughput assay, processing up to 10 samples at once, providing batch testing capabilities. We hypothesized that trauma patients who developed VTE would show distinct TG profiles compared with those who did not.

METHODS: Trauma patients presenting to a Level I Trauma Center had samples collected within 12 hours postinjury prospectively. Follow-up was conducted to 90 days, time to symptomatic VTE diagnosis or death, confirmed via autopsy or imaging. TG profiles were measured from the ST Genesia assay. Data were presented as median (interquartile ranges) or n (%), with the Wilcoxon rank-sum or chi-squared test. Associations between TG parameters and clinical risk factors were assessed using Spearman correlation analysis or the Wilcoxon rank-sum test.

RESULTS: Two hundred and fifty-four trauma patients were analyzed [48.5 years (31.0, 62.0), 72.0% male]: 64 patients with VTE (25.2%) to 190 with non-VTE. VTE pts had a median time to VTE of 8 days, with 29 developing deep venous thrombosis, 24 with pulmonary embolism, and 11 with deep venous thrombosis/pulmonary embolism. No significant differences were found in age, sex, or body mass index; significantly more VTE patients underwent surgery and blood transfusions within 24 hours. TG profiles demonstrated accelerated TG in patients who developed VTE compared with non-VTE, with significant differences in peak height ( P = 0.001), time to peak ( P = 0.021), endogenous thrombin potential ( P < 0.001), and velocity index ( P = 0.001).

CONCLUSION: TG profiles using ST Genesia can differentiate trauma patients at high risk of developing VTE. The platform suits clinical labs needing high throughput by providing batch testing capabilities.

STUDY TYPE: Prospective study with less than large effect and no negative criteria.

LEVEL OF EVIDENCE: II.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Navarro SM, Thompson RJ, MacArthur TA, et al. Assessment of Novel Platform of Thrombin Generation to Predict Venous Thromboembolism Early After Traumatic Injury: A Prospective Cohort Study. Shock. 2026. PMID: 41949808. doi:10.1097/SHK.0000000000002725

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。